Fibroblast	B-protein
growth	I-protein
factor-1	I-protein
(	O
FGF-1	B-protein
)	O
enhances	O
IL-2	B-protein
production	O
and	O
nuclear	O
translocation	O
of	O
NF-kappaB	B-protein
in	O
FGF	B-cell_line
receptor-bearing	I-cell_line
Jurkat	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Fibroblast	B-protein
growth	I-protein
factors	I-protein
(	O
FGFs	B-protein
)	O
are	O
heparin-binding	B-protein
proteins	I-protein
crucial	O
to	O
embryogenesis	O
,	O
angiogenesis	O
,	O
and	O
wound	O
healing	O
.	O

FGF-1	B-protein
is	O
abundantly	O
expressed	O
in	O
the	O
synovium	O
in	O
rheumatoid	O
arthritis	O
and	O
in	O
rejecting	O
allografts	O
,	O
sites	O
of	O
chronic	O
immune-mediated	O
inflammation	O
.	O

The	O
frequency	O
of	O
FGF-1	B-protein
-responsive	O
T	B-cell_type
cells	I-cell_type
is	O
increased	O
in	O
the	O
peripheral	O
blood	O
of	O
these	O
disorders	O
,	O
and	O
a	O
high	O
percentage	O
of	O
infiltrating	B-cell_type
T	I-cell_type
cells	I-cell_type
in	O
rheumatoid	O
arthritis	O
synovium	O
express	O
receptors	O
for	O
FGF-1	B-protein
.	O

To	O
understand	O
the	O
action	O
of	O
FGF-1	B-protein
in	O
T	B-cell_type
cells	I-cell_type
,	O
studies	O
were	O
initiated	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
that	O
express	O
the	O
signaling	O
isoform	O
of	O
FGF	B-protein
receptor-1	I-protein
.	O

These	O
experiments	O
show	O
that	O
FGF-1	B-protein
stimulation	O
of	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
provides	O
a	O
second	O
signal	O
that	O
augments	O
TCR-mediated	O
IL-2	B-protein
production	O
.	O

Analogous	O
to	O
costimulation	O
via	O
CD28	B-protein
,	O
this	O
activity	O
is	O
mediated	O
through	O
activation	O
of	O
Rel/kappaB	B-protein
,	O
a	O
family	O
of	O
transcription	B-protein
factors	I-protein
known	O
to	O
regulate	O
IL-2	B-protein
and	O
other	O
activation-inducible	B-protein
proteins	I-protein
.	O

FGF-1	B-protein
alone	O
induces	O
modest	O
nuclear	O
translocation	O
of	O
kappaB-binding	B-protein
proteins	I-protein
,	O
and	O
this	O
translocation	O
is	O
enhanced	O
by	O
the	O
combination	O
of	O
anti-CD3	B-protein
and	O
FGF-1	B-protein
.	O

This	O
NF-kappaB	B-protein
binding	I-protein
complex	I-protein
is	O
composed	O
of	O
transcriptionally	B-protein
active	I-protein
p65	I-protein
(	I-protein
RelA	I-protein
)	I-protein
/p50	I-protein
heterodimers	I-protein
and	O
results	O
primarily	O
from	O
the	O
targeted	O
degradation	O
of	O
IkappaB-alpha	B-protein
,	O
an	O
inhibitor	O
that	O
sequesters	O
Rel/kappaB	B-protein
in	O
the	O
cytoplasm	O
.	O

These	O
data	O
are	O
the	O
first	O
to	O
show	O
a	O
connection	O
between	O
FGF-1	B-protein
signaling	O
and	O
NF-kappaB	B-protein
activation	O
outside	O
of	O
embryonic	O
development	O
.	O

The	O
signaling	O
events	O
that	O
link	O
FGF	B-protein
receptor-1	I-protein
engagement	O
and	O
NF-kappaB	B-protein
activation	O
in	O
Jurkat	B-cell_line
are	O
probably	O
distinct	O
from	O
the	O
CD28	B-protein
costimulation	O
pathway	O
,	O
since	O
FGF-1	B-protein
-induced	O
Rel/kappaB	B-protein
binding	I-protein
proteins	I-protein
do	O
not	O
contain	O
significant	O
levels	O
of	O
c-Rel	B-protein
and	O
are	O
not	O
identical	O
with	O
the	O
CD28	B-protein
response	I-protein
complex	I-protein
.	O

Fibroblast	NULL
Growth	NULL
Factor-1	NULL
(	NULL
FGF-1	NULL
)	NULL
Enhances	NULL
IL-2	NULL
Production	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
of	NULL
NF-rB	NULL
in	NULL
FGF	NULL
Receptor-Bearing	NULL
Jurkat	NULL
T	NULL
Cells	NULL
!	NULL

Victor	NULL
M.	NULL
Byrd	NULL
,	NULL
``	NULL
Dean	NULL
W.	NULL
Ballard	NULL
,	NULL
Geraldine	NULL
G.	NULL
Miller	NULL
,	NULL
and	NULL
James	NULL
W.	NULL
Thomas	NULL
Fibroblast	NULL
growth	NULL
factors	NULL
(	NULL
FGFs	NULL
)	NULL
are	NULL
heparin-binding	NULL
proteins	NULL
crucial	NULL
to	NULL
embryogenesis	NULL
,	NULL
angiogenesis	NULL
,	NULL
and	NULL
wound	NULL
healing	NULL
.	NULL

FGF-1	NULL
is	NULL
abundantly	NULL
expressed	NULL
in	NULL
the	NULL
synovium	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
in	NULL
rejecting	NULL
allografts	NULL
,	NULL
sites	NULL
of	NULL
chronic	NULL
immune-mediated	NULL
inflammation	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
FGF-1-responsive	NULL
T	NULL
cells	NULL
is	NULL
increased	NULL
in	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
these	NULL
disorders	NULL
,	NULL
and	NULL
a	NULL
high	NULL
percentage	NULL
of	NULL
infiltrating	NULL
T	NULL
cells	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
synovium	NULL
express	NULL
receptors	NULL
for	NULL
FGF-1	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
action	NULL
of	NULL
FGF-1	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
studies	NULL
were	NULL
initiated	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
the	NULL
signaling	NULL
isoform	NULL
of	NULL
FGF	NULL
receptor-1	NULL
.	NULL

These	NULL
experiments	NULL
show	NULL
that	NULL
FGF-1	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
provides	NULL
a	NULL
second	NULL
signal	NULL
that	NULL
augments	NULL
TCR-mediated	NULL
IL-2	NULL
production	NULL
.	NULL

Analogous	NULL
to	NULL
costimulation	NULL
via	NULL
CD28	NULL
,	NULL
this	NULL
activity	NULL
is	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
Rel/rB	NULL
,	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
known	NULL
to	NULL
regulate	NULL
IL-2	NULL
and	NULL
other	NULL
activation-inducible	NULL
proteins	NULL
.	NULL

FGF-1	NULL
alone	NULL
induces	NULL
modest	NULL
nuclear	NULL
translocation	NULL
of	NULL
B-binding	NULL
proteins	NULL
,	NULL
and	NULL
this	NULL
translocation	NULL
is	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
FGF-1	NULL
.	NULL

This	NULL
NF-B	NULL
binding	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
transcriptionally	NULL
active	NULL
p65	NULL
(	NULL
ReIA	NULL
)	NULL
/p50	NULL
heterodimers	NULL
and	NULL
results	NULL
primarily	NULL
from	NULL
the	NULL
targeted	NULL
degradation	NULL
of	NULL
an	NULL
inhibitor	NULL
that	NULL
sequesters	NULL
Rel/rB	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

These	NULL
data	NULL
are	NULL
the	NULL
first	NULL
to	NULL
show	NULL
a	NULL
connection	NULL
between	NULL
FGF-1	NULL
signaling	NULL
and	NULL
NF-rB	NULL
activation	NULL
outside	NULL
of	NULL
embryonic	NULL
development	NULL
.	NULL

The	NULL
signaling	NULL
events	NULL
that	NULL
link	NULL
FGF	NULL
receptor-1	NULL
engagement	NULL
and	NULL
activation	NULL
in	NULL
Jurkat	NULL
are	NULL
probably	NULL
distinct	NULL
from	NULL
the	NULL
CD28	NULL
costimulation	NULL
pathway	NULL
,	NULL
since	NULL
FGF-1-induced	NULL
Rel/B	NULL
binding	NULL
proteins	NULL
do	NULL
not	NULL
contain	NULL
significant	NULL
levels	NULL
of	NULL
c-Rel	NULL
and	NULL
are	NULL
not	NULL
identical	NULL
with	NULL
the	NULL
CD28	NULL
response	NULL
complex	NULL
.	NULL

cidic	NULL
and	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factors	NULL
(	NULL
FGPF-1	NULL
and	NULL
A	NULL
FGF-2	NULL
)	NULL
``	NULL
are	NULL
prototypes	NULL
of	NULL
heparin	NULL
binding	NULL
growth	NULL
fac-	NULL
tors	NULL
that	NULL
stimulate	NULL
proliferation	NULL
,	NULL
migration	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
cells	NULL
of	NULL
neuroectodermal	NULL
and	NULL
mesodermal	NULL
origin	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1-4	NULL
)	NULL
.	NULL

They	NULL
are	NULL
expressed	NULL
widely	NULL
during	NULL
normal	NULL
embryonic	NULL
development	NULL
and	NULL
often	NULL
in	NULL
adult	NULL
tissues	NULL
at	NULL
sites	NULL
of	NULL
injury	NULL
,	NULL
where	NULL
their	NULL
angiogenic	NULL
activity	NULL
contributes	NULL
to	NULL
wound	NULL
healing	NULL
.	NULL

FGE-1	NULL
expression	NULL
is	NULL
markedly	NULL
increased	NULL
in	NULL
some	NULL
sites	NULL
of	NULL
chronic	NULL
immunologic	NULL
injury	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
synovium	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
(	NULL
5-8	NULL
)	NULL
and	NULL
in	NULL
allografts	NULL
undergoing	NULL
chronic	NULL
rejection	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
where	NULL
T	NULL
cell	NULL
infiltration	NULL
is	NULL
common	NULL
.	NULL

Early	NULL
evidence	NULL
of	NULL
a	NULL
direct	NULL
connection	NULL
between	NULL
T	NULL
cells	NULL
and	NULL
nonhemopoietic	NULL
growth	NULL
factors	NULL
including	NULL
FGF	NULL
was	NULL
first	NULL
reported	NULL
by	NULL
Johnson	NULL
and	NULL
Torres	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Their	NULL
experiments	NULL
demonstrated	NULL
that	NULL
CD8*	NULL
T	NULL
cells	NULL
produced	NULL
IFN-y	NULL
when	NULL
stimulated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
FGF	NULL
and	NULL
TCR	NULL
engagement	NULL
by	NULL
superantigen	NULL
,	NULL
while	NULL
neither	NULL
stimulus	NULL
alone	NULL
induced	NULL
cytokine	NULL
production	NULL
.	NULL

Their	NULL
data	NULL
thus	NULL
suggested	NULL
that	NULL
FGF	NULL
and	NULL
other	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Microbiology/Immunology	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
Received	NULL
for	NULL
publication	NULL
November	NULL
20	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
1	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

'This	NULL
work	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
(	NULL
to	NULL
V.M.B	NULL
.	NULL
)	NULL

KO8ARO2017	NULL
,	NULL
RO1AI33839	NULL
(	NULL
to	NULL
D.W.B	NULL
.	NULL
)	NULL

,	NULL
ROIHL53771	NULL
(	NULL
to	NULL
G.GM	NULL
.	NULL
)	NULL

,	NULL
and	NULL
RO1AR43653	NULL
(	NULL
to	NULL
J.W.T	NULL
.	NULL
)	NULL

;	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
D.W.B	NULL
.	NULL
)	NULL

,	NULL
and	NULL
American	NULL
Heart	NULL
Association	NULL
Grant-in-Aid	NULL
94006080.	NULL
?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Victor	NULL
M.	NULL
Byrd	NULL
,	NULL
Department	NULL
of	NULL
Medicine/Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
Vanderbilt	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
T3219	NULL
MCN	NULL
21st	NULL
Ave.	NULL
and	NULL
Garland	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
victor.m.byrd	NULL
@	NULL
vanderbilt.edu	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PGF	NULL
,	NULL
fibroblast	NULL
growth	NULL
factor	NULL
;	NULL
RA	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
;	NULL
FGFR-1	NULL
,	NULL
FGF	NULL
receptor-1	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
CD28RE	NULL
,	NULL
CD28	NULL
response	NULL
element	NULL
;	NULL
ATF-2	NULL
,	NULL
activating	NULL
transcription	NULL
factor-2	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
CD28RC	NULL
,	NULL
CD28	NULL
response	NULL
complex	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
5853-5859.	NULL
peptide	NULL
growth	NULL
hormones	NULL
provided	NULL
a	NULL
second	NULL
or	NULL
costimulatory	NULL
signal	NULL
required	NULL
for	NULL
cytokine	NULL
production	NULL
.	NULL

More	NULL
recent	NULL
experiments	NULL
show	NULL
that	NULL
a	NULL
subset	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
expresses	NULL
FGF	NULL
receptor-1	NULL
(	NULL
FGFR-1	NULL
)	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
,	NULL
a	NULL
high	NULL
affinity	NULL
receptor	NULL
tyrosine	NULL
kinase	NULL
that	NULL
mediates	NULL
FGF	NULL
signaling	NULL
in	NULL
many	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

14	NULL
)	NULL
.	NULL

For	NULL
CD4*	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
FGFR-1	NULL
,	NULL
FGF-1	NULL
can	NULL
provide	NULL
the	NULL
costimulatory	NULL
signal	NULL
required	NULL
for	NULL
IL-2	NULL
production	NULL
in	NULL
conjunction	NULL
with	NULL
anti-CD3	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

FGF-1	NULL
alone	NULL
,	NULL
however	NULL
,	NULL
does	NULL
not	NULL
induce	NULL
IL-2	NULL
production	NULL
,	NULL
and	NULL
in	NULL
contrast	NULL
to	NULL
other	NULL
cell	NULL
types	NULL
that	NULL
express	NULL
FGEFR-1	NULL
,	NULL
FGF-1	NULL
alone	NULL
is	NULL
unable	NULL
to	NULL
induce	NULL
T	NULL
cell	NULL
proliferation	NULL
.	NULL

Whether	NULL
this	NULL
reflects	NULL
the	NULL
dependence	NULL
of	NULL
T	NULL
cells	NULL
upon	NULL
IL-2	NULL
for	NULL
proliferation	NULL
or	NULL
differences	NULL
in	NULL
FGFR-1	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
vs	NULL
other	NULL
cell	NULL
types	NULL
is	NULL
unknown	NULL
.	NULL

FGFR	NULL
signaling	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
induces	NULL
receptor	NULL
oligomer-ization	NULL
and	NULL
autophosphorylation	NULL
with	NULL
resultant	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
phospholipase	NULL
Cy	NULL
and	NULL
activation	NULL
of	NULL
Ras/MAPK/extra-cellular	NULL
signal-related	NULL
kinase	NULL
(	NULL
ERK	NULL
)	NULL
(	NULL
14-16	NULL
)	NULL
,	NULL
which	NULL
are	NULL
also	NULL
activated	NULL
by	NULL
the	NULL
TCR	NULL
pathway	NULL
.	NULL

IL-2	NULL
production	NULL
resulting	NULL
from	NULL
the	NULL
combination	NULL
of	NULL
TCR	NULL
and	NULL
FGF-1	NULL
signaling	NULL
,	NULL
therefore	NULL
,	NULL
presumably	NULL
reflects	NULL
an	NULL
integration	NULL
of	NULL
signals	NULL
from	NULL
these	NULL
two	NULL
pathways	NULL
and	NULL
their	NULL
resultant	NULL
transcription	NULL
factor	NULL
activation	NULL
.	NULL

Among	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
signaling	NULL
through	NULL
FGFR-1	NULL
in	NULL
nonlym-phoid	NULL
cells	NULL
are	NULL
AP-1	NULL
and	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein/	NULL
activating	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
,	NULL
and	NULL
most	NULL
recently	NULL
members	NULL
of	NULL
the	NULL
FGF	NULL
family	NULL
were	NULL
shown	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
to	NULL
induce	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
in	NULL
the	NULL
developing	NULL
limb	NULL
bud	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

Engagement	NULL
of	NULL
CD28	NULL
by	NULL
its	NULL
receptor	NULL
ligands	NULL
on	NULL
APCs	NULL
is	NULL
to	NULL
date	NULL
the	NULL
predominant	NULL
interaction	NULL
between	NULL
T	NULL
cell	NULL
and	NULL
APC	NULL
surface	NULL
molecules	NULL
that	NULL
provide	NULL
costimulation	NULL
for	NULL
IL-2	NULL
production	NULL
,	NULL
thus	NULL
inducing	NULL
T	NULL
cell	NULL
expansion	NULL
and	NULL
preventing	NULL
anergy	NULL
or	NULL
apoptosis	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
factors	NULL
is	NULL
a	NULL
major	NULL
target	NULL
of	NULL
the	NULL
costimulatory	NULL
activity	NULL
of	NULL
the	NULL
CD28	NULL
pathway	NULL
(	NULL
21-24	NULL
)	NULL
.	NULL

Indirect	NULL
evidence	NULL
suggests	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
5854	NULL
that	NULL
FGF-1	NULL
may	NULL
also	NULL
have	NULL
costimulatory	NULL
function	NULL
in	NULL
vivo	NULL
,	NULL
especially	NULL
at	NULL
sights	NULL
such	NULL
as	NULL
the	NULL
synovium	NULL
in	NULL
active	NULL
RA	NULL
and	NULL
the	NULL
paren-chyma	NULL
of	NULL
solid	NULL
organ	NULL
allografts	NULL
,	NULL
where	NULL
FGP-1	NULL
production	NULL
is	NULL
excessive	NULL
(	NULL
5	NULL
,	NULL
7-10	NULL
)	NULL
.	NULL

Patients	NULL
with	NULL
RA	NULL
and	NULL
cardiac	NULL
transplant	NULL
recipients	NULL
have	NULL
5-	NULL
to	NULL
10-fold	NULL
increases	NULL
in	NULL
the	NULL
precursor	NULL
frequency	NULL
of	NULL
FGF-responsive	NULL
T	NULL
cells	NULL
in	NULL
peripheral	NULL
blood	NULL
compared	NULL
with	NULL
normal	NULL
subjects	NULL
,	NULL
and	NULL
changes	NULL
in	NULL
the	NULL
frequency	NULL
of	NULL
these	NULL
cells	NULL
over	NULL
time	NULL
are	NULL
correlated	NULL
with	NULL
disease	NULL
activity	NULL
in	NULL
RA	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Enrichment	NULL
of	NULL
FGFR-1*	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
RA	NULL
synovium	NULL
compared	NULL
with	NULL
peripheral	NULL
blood	NULL
suggests	NULL
that	NULL
local	NULL
FGF-1	NULL
may	NULL
contribute	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
differentiation	NULL
,	NULL
or	NULL
survival	NULL
within	NULL
inflammatory	NULL
sites	NULL
.	NULL

To	NULL
improve	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
actions	NULL
on	NULL
T	NULL
cells	NULL
independent	NULL
of	NULL
these	NULL
complex	NULL
inflammatory	NULL
events	NULL
,	NULL
we	NULL
initiated	NULL
studies	NULL
using	NULL
a	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
the	NULL
signaling	NULL
isoform	NULL
of	NULL
FGFR-1	NULL
.	NULL

Evidence	NULL
for	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
by	NULL
FGFs	NULL
expressed	NULL
in	NULL
the	NULL
developing	NULL
limb	NULL
and	NULL
the	NULL
parallels	NULL
with	NULL
CD28	NULL
costimulation	NULL
in	NULL
T	NULL
cells	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
FGFR-1	NULL
signaling	NULL
activates	NULL
NF-	NULL
«	NULL
B/Rel	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
FGF-1	NULL
induces	NULL
enhanced	NULL
degradation	NULL
of	NULL
cytoplasmic	NULL
IxB-	NULL
«	NULL
and	NULL
prolonged	NULL
nuclear	NULL
translocation	NULL
of	NULL
transcriptionally	NULL
active	NULL
p50/ReIA	NULL
heterodimers	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
costimulation	NULL
via	NULL
CD28	NULL
,	NULL
FGF-induced	NULL
Rel/xB	NULL
complexes	NULL
contained	NULL
low	NULL
levels	NULL
of	NULL
c-Rel	NULL
,	NULL
and	NULL
no	NULL
binding	NULL
to	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
FGE-1	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
some	NULL
functions	NULL
of	NULL
FGF-1	NULL
outside	NULL
embryonic	NULL
development	NULL
are	NULL
mediated	NULL
by	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
and	NULL
that	NULL
signals	NULL
from	NULL
a	NULL
nonhemopoietic	NULL
growth	NULL
factor	NULL
and	NULL
the	NULL
TCR	NULL
pathways	NULL
may	NULL
intersect	NULL
.	NULL

The	NULL
implications	NULL
for	NULL
these	NULL
findings	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
nontransformed	NULL
T	NULL
cells	NULL
is	NULL
discussed	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
Jurkat	NULL
T	NULL
cells	NULL
expressing	NULL
FGFR-18	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
they	NULL
were	NULL
produced	NULL
by	NULL
stable	NULL
transfection	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
FGFR-16	NULL
cDNA	NULL
driven	NULL
by	NULL
the	NULL
CD2	NULL
promoter	NULL
and	NULL
locus	NULL
control	NULL
region	NULL
.	NULL

These	NULL
cells	NULL
(	NULL
clone	NULL
C2-14	NULL
)	NULL
express	NULL
approximately	NULL
30,000	NULL
high	NULL
affinity	NULL
FGFR	NULL
and	NULL
were	NULL
used	NULL
for	NULL
all	NULL
the	NULL
experiments	NULL
described	NULL
here	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
routinely	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
5	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
1	NULL
mg/ml	NULL
G418	NULL
.	NULL

For	NULL
T	NULL
cell	NULL
stimulations	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
six-well	NULL
flat-bottom	NULL
plates	NULL
coated	NULL
with	NULL
anti-CD3	NULL
(	NULL
1	NULL
pg/ml	NULL
mAb	NULL
JE6	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
Stanford	NULL
Stewart	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
FGF-1	NULL
or	NULL
FGF-2	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
or	NULL
anti-CD28	NULL
(	NULL
mAb	NULL
9.3	NULL
,	NULL
1/2,500	NULL
,	NULL
provided	NULL
by	NULL
Dr.	NULL
Jeffrey	NULL
Ledbetter	NULL
,	NULL
Bristol	NULL
Myers	NULL
Squibb	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
were	NULL
included	NULL
as	NULL
indicated	NULL
.	NULL

All	NULL
stimulations	NULL
with	NULL
FGF-1	NULL
or	NULL
FGF-2	NULL
included	NULL
heparin	NULL
(	NULL
20	NULL
U/ml	NULL
)	NULL
.	NULL

For	NULL
determinations	NULL
of	NULL
IL-2	NULL
protein	NULL
production	NULL
,	NULL
supernatants	NULL
were	NULL
harvested	NULL
at	NULL
24	NULL
h	NULL
and	NULL
were	NULL
assayed	NULL
by	NULL
ELISA	NULL
(	NULL
BioSource	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
extract	NULL
preparation	NULL
Nuclear	NULL
and	NULL
cytoplasmic	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
)	NULL
from	NULL
10	NULL
``	NULL
T	NULL
cells	NULL
harvested	NULL
at	NULL
each	NULL
time	NULL
point	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
in	NULL
1.0	NULL
ml	NULL
of	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
cell	NULL
pellets	NULL
were	NULL
lysed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
10	NULL
mM	NULL
KC	NULL
]	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.4	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
antipain	NULL
,	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
bestatin	NULL
,	NULL
phosphorami-don	NULL
,	NULL
and	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
all	NULL
5	NULL
pg/ml	NULL
,	NULL
and	NULL
pepstatin	NULL
0.5	NULL
ug/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
cell	NULL
lysates	NULL
were	NULL
subsequently	NULL
centrifuged	NULL
for	NULL
60	NULL
s	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
collected	NULL
for	NULL
cytoplasmic	NULL
protein	NULL
analysis	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
from	NULL
lysis	NULL
was	NULL
washed	NULL
briefly	NULL
in	NULL
100	NULL
gl	NULL
of	NULL
lysis	NULL
buffer	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
high	NULL
salt	NULL
extraction	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
nuclear	NULL
buffer	NULL
(	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
)	NULL
at	NULL
4°C	NULL
with	NULL
extensive	NULL
shaking	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cellular	NULL
debris	NULL
from	NULL
both	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
was	NULL
removed	NULL
by	NULL
cen-trifugation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
14,000	NULL
X	NULL
g	NULL
,	NULL
and	NULL
fractions	NULL
were	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
analyzed	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
spectrophoto-metric	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
FGF-1	NULL
EMSA/supershift	NULL
assays	NULL
For	NULL
EMSA	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
°°P-labeled	NULL
duplex	NULL
probe	NULL
including	NULL
1	NULL
)	NULL
a	NULL
palindromic	NULL
NF-KB	NULL
site	NULL
derived	NULL
from	NULL
the	NULL
IL-2R-a	NULL
«	NULL
promoter	NULL
(	NULL
5-CAACGGCAGGGGAATTCCCCTCTCCTITT-3	NULL
``	NULL
)	NULL
(	NULL
27	NULL
)	NULL
,	NULL
or	NULL
2	NULL
)	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
;	NULL
5-GATCGTTITAAA-GAAATTCCAAA-3	NULL
'	NULL
)	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Incubations	NULL
were	NULL
performed	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
125	NULL
mM	NULL
NaCl	NULL
,	NULL
2.5	NULL
mM	NULL
EDNA	NULL
,	NULL
0.25	NULL
mM	NULL
DTT	NULL
,	NULL
0.25	NULL
mM	NULL
PMSF	NULL
,	NULL
0.5	NULL
mg/ml	NULL
BSA	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
0.1	NULL
mg/ml	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Approximately	NULL
100,000	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
probe	NULL
was	NULL
used	NULL
per	NULL
sample	NULL
.	NULL

Resultant	NULL
nu-cleoprotein	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacryl-amide	NULL
gel	NULL
in	NULL
TBE	NULL
buffer	NULL
(	NULL
90	NULL
mM	NULL
Tris	NULL
,	NULL
90	NULL
mM	NULL
borate	NULL
,	NULL
2.5	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
both	NULL
probes	NULL
,	NULL
the	NULL
specificity	NULL
of	NULL
protein-oligonucleotide	NULL
interactions	NULL
was	NULL
verified	NULL
by	NULL
competition	NULL
of	NULL
radiolabeled	NULL
probe	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
DNA/protein	NULL
complexes	NULL
were	NULL
incubated	NULL
with	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
to	NULL
members	NULL
of	NULL
the	NULL
Rel/	NULL
«	NULL
B	NULL
family	NULL
,	NULL
including	NULL
p65	NULL
(	NULL
ReIA	NULL
)	NULL
(	NULL
antiserum	NULL
R567	NULL
)	NULL
(	NULL
26	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
antiserum	NULL
R393	NULL
)	NULL
(	NULL
28	NULL
)	NULL
,	NULL
or	NULL
preimmune	NULL
sera	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
as	NULL
detailed	NULL
above	NULL
.	NULL

Nuclear	NULL
proteins	NULL
(	NULL
60	NULL
pug	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
membranes	NULL
,	NULL
and	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
in	NULL
Tris-buffered	NULL
saline/Tween	NULL
.	NULL

Proteins	NULL
were	NULL
subsequently	NULL
immunoblotted	NULL
with	NULL
polyclonal	NULL
antiserum	NULL
specific	NULL
for	NULL
c-Rel	NULL
(	NULL
antiserum	NULL
R453	NULL
,	NULL
1/2000	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cytosolic	NULL
IxB	NULL
,	NULL
cytoplasmic	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
as	NULL
detailed	NULL
above	NULL
,	NULL
except	NULL
that	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
(	NULL
50	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
to	NULL
block	NULL
the	NULL
NF-xB-induced	NULL
resynthesis	NULL
of	NULL
IB	NULL
inhibitors	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
proteins	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
membranes	NULL
,	NULL
and	NULL
blocked	NULL
as	NULL
detailed	NULL
above	NULL
.	NULL

Proteins	NULL
were	NULL
immunoblotted	NULL
with	NULL
polyclonal	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
IB-	NULL
«	NULL
(	NULL
antiserum	NULL
R663	NULL
,	NULL
1/2500	NULL
)	NULL
(	NULL
26	NULL
)	NULL
or	NULL
IxB-B	NULL
(	NULL
antiserum	NULL
C-20	NULL
,	NULL
1/200	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Immunoreactive	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
assay	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Jurkat	NULL
transient	NULL
transfections	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assay	NULL
Jurkat	NULL
C2-14	NULL
was	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
a	NULL
vector	NULL
containing	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
NF-KB	NULL
sequence	NULL
from	NULL
the	NULL
HIV-1	NULL
promoter	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Electroporation	NULL
conditions	NULL
(	NULL
250	NULL
V	NULL
,	NULL
960	NULL
uF	NULL
,	NULL
time	NULL
constant	NULL
34	NULL
)	NULL
were	NULL
optimized	NULL
to	NULL
a	NULL
viable	NULL
cell	NULL
recovery	NULL
of	NULL
50	NULL
%	NULL
.	NULL

Cells	NULL
were	NULL
rested	NULL
for	NULL
24	NULL
h	NULL
in	NULL
RPMI/10	NULL
%	NULL
FCS	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
for	NULL
24	NULL
h	NULL
and	NULL
assay	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
whole	NULL
cell	NULL
lysates	NULL
by	NULL
a	NULL
diffusion-based	NULL
liquid	NULL
scintillation	NULL
method	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Results	NULL
FGF-1	NULL
and	NULL
FGF-2	NULL
act	NULL
as	NULL
costimulatory	NULL
signals	NULL
for	NULL
IL-2	NULL
production	NULL
in	NULL
FGFR-1-expressing	NULL
T	NULL
cells	NULL
Optimal	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
dependent	NULL
upon	NULL
signals	NULL
generated	NULL
by	NULL
TCR	NULL
engagement	NULL
and	NULL
costimulatory	NULL
signals	NULL
provided	NULL
by	NULL
additional	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
costimulatory	NULL
effects	NULL
of	NULL
FGF-1	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
FGFR-1	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
alone	NULL
,	NULL
FGF-1	NULL
alone	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
FGF-1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Unstimulated	NULL
T	NULL
cells	NULL
and	NULL
those	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
alone	NULL
(	NULL
zero	NULL
FGF	NULL
point	NULL
on	NULL
the	NULL
anti-CD3	NULL
plus	NULL
FGF	NULL
curve	NULL
)	NULL
or	NULL
FGF-1	NULL
alone	NULL
produced	NULL
little	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
anti-CD3	NULL
with	NULL
FGF-1	NULL
increased	NULL
IL-2	NULL
production	NULL
approximately	NULL
7-fold	NULL
over	NULL
that	NULL
with	NULL
anti-CD3	NULL
alone	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
FGE-2	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
FGFR-1	NULL
binds	NULL
both	NULL
these	NULL
FGF	NULL
family	NULL
members	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL

Positive	NULL
control	NULL
stimulations	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
resulted	NULL
in	NULL
significant	NULL
IL-2	NULL
production	NULL
(	NULL
mean	NULL
,	NULL
1423	NULL
pg/ml	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
previous	NULL
findings	NULL
that	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
together	NULL
with	NULL
stimulation	NULL
by	NULL
FGF-1	NULL
induces	NULL
both	NULL
IL-2	NULL
production	NULL
and	NULL
proliferation	NULL
,	NULL
whereas	NULL
FGF-1	NULL
alone	NULL
is	NULL
ineffective	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
500	NULL
450	NULL
-	NULL
v	NULL
Unstim	NULL
400	NULL
-	NULL
0	NULL
A	NULL
FGF-1	NULL
alone	NULL
//	NULL
@	NULL
anti-=-CD3	NULL
+	NULL
a	NULL
350	NULL
4	NULL
FGF	NULL
-1	NULL
3	NULL
O	NULL
anti-CD3	NULL
+	NULL
vy	NULL
$	NULL
00	NULL
7	NULL
FGF-2	NULL
o	NULL
.	NULL

~	NULL
250	NULL
4	NULL
T	NULL
=	NULL
200	NULL
150	NULL
100	NULL
501	NULL
y	NULL
A	NULL
0	NULL
I	NULL
T	NULL
I	NULL
I	NULL
0	NULL
1	NULL
10	NULL
100	NULL
FGF	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

FIGURE	NULL
1	NULL
.	NULL

FGF-1	NULL
and	NULL
FGF-2	NULL
provide	NULL
costimulatory	NULL
signals	NULL
for	NULL
IL-2	NULL
production	NULL
in	NULL
FGFR-1*	NULL
T	NULL
cells	NULL
.	NULL

FGFR-1-transfected	NULL
Jurkat	NULL
cells	NULL
(	NULL
subline	NULL
C2-14	NULL
)	NULL
were	NULL
plated	NULL
at	NULL
1	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
and	NULL
stimulated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
,	NULL
FGPF-1	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
increasing	NULL
concentrations	NULL
of	NULL
FGF-1	NULL
or	NULL
FGF-2	NULL
(	NULL
0-100	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD3	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
24-h	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
assayed	NULL
for	NULL
IL-2	NULL
by	NULL
ELISA	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
IL-2	NULL
production	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Positive	NULL
control	NULL
stimulations	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
resulted	NULL
in	NULL
IL-2	NULL
production	NULL
with	NULL
a	NULL
mean	NULL
of	NULL
1423	NULL
pg/ml	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

FGF-1	NULL
stimulation	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
«	NULL
kB	NULL
binding	NULL
proteins	NULL
Activation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
TCR	NULL
together	NULL
with	NULL
costimulation	NULL
via	NULL
CD28	NULL
result	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
(	NULL
23	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
whether	NULL
FGF-1	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
TCR	NULL
engagement	NULL
similarly	NULL
activates	NULL
NF-KB	NULL
.	NULL

Gel	NULL
shifts	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
palindromic	NULL
B	NULL
sequence	NULL
derived	NULL
from	NULL
the	NULL
IL-2R	NULL
-chain	NULL
enhancer	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
FGF-1	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Modest	NULL
induction	NULL
of	NULL
NF-KB	NULL
binding	NULL
activity	NULL
was	NULL
present	NULL
by	NULL
30	NULL
min	NULL
after	NULL
addition	NULL
of	NULL
FGF-1	NULL
and	NULL
remained	NULL
detectable	NULL
with	NULL
relatively	NULL
little	NULL
change	NULL
during	NULL
6	NULL
h	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FGE-1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimulation	NULL
with	NULL
both	NULL
anti-CD3	NULL
and	NULL
FGF-1	NULL
led	NULL
to	NULL
enhanced	NULL
binding	NULL
compared	NULL
with	NULL
either	NULL
stimulus	NULL
alone	NULL
,	NULL
and	NULL
binding	NULL
activity	NULL
increased	NULL
substantially	NULL
over	NULL
time	NULL
up	NULL
to	NULL
12	NULL
h	NULL
in	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
activation	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
on	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
anti-CD28	NULL
and	NULL
detected	NULL
a	NULL
similar	NULL
kB	NULL
binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
with	NULL
unlabeled	NULL
competitor	NULL
probe	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
binding	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
,	NULL
supershifts	NULL
were	NULL
performed	NULL
with	NULL
antisera	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
and	NULL
with	NULL
control	NULL
nonimmune	NULL
serum	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
alone	NULL
,	NULL
anti-CD3	NULL
plus	NULL
FGF-1	NULL
,	NULL
and	NULL
positive	NULL
controls	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
in	NULL
all	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
B	NULL
sequence	NULL
.	NULL

The	NULL
data	NULL
thus	NULL
indicate	NULL
that	NULL
stimulation	NULL
by	NULL
FGF-1	NULL
results	NULL
in	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
that	NULL
is	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
TCR	NULL
and	NULL
FGEFR	NULL
signaling	NULL
.	NULL

FGF-1	NULL
costimulation	NULL
does	NULL
not	NULL
result	NULL
in	NULL
increased	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel	NULL
As	NULL
supershift	NULL
assays	NULL
using	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
c-Rel	NULL
did	NULL
not	NULL
produce	NULL
convincing	NULL
mobility	NULL
shifts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
Western	NULL
blotting	NULL
for	NULL
c-Rel	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
either	NULL
FGEF-1	NULL
or	NULL
anti-CD28	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
no	NULL
appreciable	NULL
in	NULL
5855	NULL
crease	NULL
in	NULL
c-Rel	NULL
nuclear	NULL
translocation	NULL
following	NULL
stimulation	NULL
with	NULL
FGE-1	NULL
alone	NULL
or	NULL
anti-CD3	NULL
alone	NULL
and	NULL
a	NULL
very	NULL
modest	NULL
increase	NULL
in	NULL
c-Rel	NULL
following	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
plus	NULL
FGEF-1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
marked	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel	NULL
was	NULL
noted	NULL
following	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
in	NULL
combination	NULL
with	NULL
anti-CD28	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
FGF-induced	NULL
Rel/kB	NULL
complexes	NULL
differ	NULL
from	NULL
those	NULL
activated	NULL
by	NULL
anti-CD28	NULL
pathways	NULL
,	NULL
as	NULL
FGF-induced	NULL
complexes	NULL
contain	NULL
little	NULL
c-Rel	NULL
.	NULL

FGF-1	NULL
costimulation	NULL
does	NULL
not	NULL
induce	NULL
nuclear	NULL
translocation	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
Activation	NULL
through	NULL
CD28	NULL
,	NULL
but	NULL
not	NULL
other	NULL
costimulators	NULL
(	NULL
23	NULL
)	NULL
,	NULL
results	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
nuclear	NULL
CD28	NULL
response	NULL
complex	NULL
(	NULL
CD28RC	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
designated	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
present	NULL
in	NULL
several	NULL
genes	NULL
including	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
23	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Since	NULL
FGF-1	NULL
costimulation	NULL
enhances	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
which	NULL
are	NULL
components	NULL
of	NULL
the	NULL
CD28RC	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
it	NULL
also	NULL
results	NULL
in	NULL
a	NULL
complex	NULL
that	NULL
binds	NULL
the	NULL
CD28RE	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
probe	NULL
for	NULL
the	NULL
CD28RE	NULL
sequence	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
with	NULL
FGF-1	NULL
alone	NULL
in	NULL
combination	NULL
with	NULL
anti-CD3	NULL
or	NULL
from	NULL
controls	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
controls	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
showed	NULL
the	NULL
expected	NULL
binding	NULL
to	NULL
the	NULL
CD28RE	NULL
probe	NULL
,	NULL
while	NULL
cells	NULL
stimulated	NULL
with	NULL
FGE-1	NULL
,	NULL
anti-CD28	NULL
alone	NULL
,	NULL
anti-CD3	NULL
alone	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
FGF-1	NULL
did	NULL
not	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
costimulation	NULL
by	NULL
FGF-1	NULL
does	NULL
not	NULL
activate	NULL
formation	NULL
of	NULL
the	NULL
protein	NULL
complex	NULL
that	NULL
binds	NULL
this	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
that	NULL
signaling	NULL
pathways	NULL
from	NULL
CD28	NULL
and	NULL
FGFR-1	NULL
are	NULL
not	NULL
identical	NULL
.	NULL

NF-KB	NULL
proteins	NULL
activated	NULL
by	NULL
FGF-1	NULL
costimulation	NULL
are	NULL
transcriptionally	NULL
active	NULL
To	NULL
confirm	NULL
that	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
complex	NULL
induced	NULL
by	NULL
FGF-1	NULL
costimulation	NULL
was	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
transfections	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
construct	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
stimulation	NULL
with	NULL
either	NULL
anti-CD3	NULL
or	NULL
FGF-1	NULL
alone	NULL
resulted	NULL
in	NULL
only	NULL
a	NULL
2-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
above	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Costimulation	NULL
with	NULL
FGF-1	NULL
and	NULL
anti-CD3	NULL
resulted	NULL
in	NULL
an	NULL
average	NULL
5-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
7	NULL
.	NULL

A-fold	NULL
increase	NULL
seen	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
.	NULL

The	NULL
results	NULL
demonstrate	NULL
that	NULL
both	NULL
FGF-1	NULL
and	NULL
CD28	NULL
costimulatory	NULL
pathways	NULL
induce	NULL
Rel/kB	NULL
protein	NULL
complexes	NULL
that	NULL
are	NULL
transcriptionally	NULL
active	NULL
.	NULL

Costimulation	NULL
with	NULL
FGF-1	NULL
targets	NULL
IxB-a	NULL
for	NULL
degradation	NULL
Rel/NF-	NULL
«	NULL
B	NULL
proteins	NULL
are	NULL
retained	NULL
in	NULL
an	NULL
inactive	NULL
state	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
inhibitors	NULL
(	NULL
IB	NULL
)	NULL
that	NULL
prevent	NULL
their	NULL
nuclear	NULL
translocation	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Activating	NULL
signals	NULL
result	NULL
in	NULL
phosphorylation	NULL
of	NULL
these	NULL
inhibitors	NULL
and	NULL
their	NULL
subsequent	NULL
degradation	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Costimulation	NULL
via	NULL
CD28	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
degradation	NULL
of	NULL
both	NULL
I	NULL
«	NULL
B-a	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
and	NULL
IxB-	NULL
$	NULL
B	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
FGF-1	NULL
stimulation	NULL
similarly	NULL
results	NULL
in	NULL
degradation	NULL
of	NULL
IB	NULL
,	NULL
Western	NULL
blots	NULL
were	NULL
performed	NULL
for	NULL
IxB-a	NULL
and	NULL
IxB-f	NULL
on	NULL
cytoplasmic	NULL
extracts	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
alone	NULL
or	NULL
anti-CD3	NULL
plus	NULL
FGF-1	NULL
.	NULL

Because	NULL
active	NULL
NF-kB	NULL
induces	NULL
synthesis	NULL
of	NULL
protein	NULL
(	NULL
30	NULL
)	NULL
,	NULL
cycloheximide	NULL
was	NULL
added	NULL
to	NULL
cultures	NULL
to	NULL
prevent	NULL
new	NULL
protein	NULL
synthesis	NULL
and	NULL
therefore	NULL
the	NULL
resynthesis	NULL
of	NULL
IKxB-a	NULL
@	NULL
induced	NULL
by	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Compared	NULL
with	NULL
stimulation	NULL
with	NULL
anti-CD3	NULL
alone	NULL
,	NULL
costimulation	NULL
with	NULL
FGE-1	NULL
resulted	NULL
in	NULL
enhanced	NULL
degradation	NULL
of	NULL
IkB-a	NULL
with	NULL
earlier	NULL
kinetics	NULL
.	NULL

Decreased	NULL
levels	NULL
of	NULL
IxB-a	NULL
were	NULL
apparent	NULL
by	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
,	NULL
and	NULL
degradation	NULL
was	NULL
virtually	NULL
complete	NULL
by	NULL
4	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
degradation	NULL
of	NULL
IxB-B	NULL
was	NULL
seen	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
for	NULL
degradation	NULL
of	NULL
IkB-a	NULL
following	NULL
costimulation	NULL
with	NULL
anti-CD28	NULL
.	NULL

5856	NULL
FIGURE	NULL
2	NULL
.	NULL

FGF-1	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
Rel/xB	NULL
proteins	NULL
.	NULL

A	NULL
,	NULL
The	NULL
Jurkat	NULL
line	NULL
C2-14	NULL
was	NULL
stimulated	NULL
with	NULL
FGF-1	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
detailed	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
°°P-labeled	NULL
probe	NULL
from	NULL
the	NULL
IL-2Ra	NULL
NF-	NULL
«	NULL
B	NULL
enhancer	NULL
sequence	NULL
.	NULL

The	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
is	NULL
marked	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

A	NULL
lower	NULL
m.w	NULL
.	NULL

band	NULL
,	NULL
present	NULL
in	NULL
all	NULL
samples	NULL
,	NULL
represented	NULL
nonspecific	NULL
binding	NULL
.	NULL

B	NULL
,	NULL
Stimulation	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-CD3	NULL
plus	NULL
FGE-1	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
FGF-1	NULL
alone	NULL
for	NULL
1	NULL
h	NULL
,	NULL
anti-CD3	NULL
alone	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
FGF-1	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
over	NULL
a	NULL
12-h	NULL
time	NULL
course	NULL
;	NULL
with	NULL
anti-CD3	NULL
plus	NULL
anti-CD28	NULL
for	NULL
1	NULL
h	NULL
;	NULL
or	NULL
with	NULL
anti-€CD28	NULL
alone	NULL
for	NULL
1	NULL
h.	NULL
Gel	NULL
shifts	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
the	NULL
labeled	NULL
NF-xB	NULL
oligonucleotide	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
in	NULL
A	NULL
above	NULL
.	NULL

Binding	NULL
of	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
gel	NULL
from	NULL
three	NULL
experiments	NULL
.	NULL

C	NULL
,	NULL
Supershift	NULL
assays	NULL
for	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
the	NULL
4	NULL
h	NULL
points	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
incubated	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
preimmune	NULL
serum	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
anti-p50	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
anti-p65	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
electrophoretic	NULL
separation	NULL
and	NULL
autoradiography	NULL
.	NULL

The	NULL
kB	NULL
binding	NULL
complexes	NULL
,	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
,	NULL
were	NULL
supershifted	NULL
by	NULL
both	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
FGF-1	NULL
unstim	NULL
0.5	NULL
hr	NULL
1	NULL
hr	NULL
2	NULL
hr	NULL
4	NULL
hbr	NULL
6	NULL
hr	NULL
tims	NULL
t	NULL
a	NULL
'	NULL
<	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
e	NULL
pas	NULL
.	NULL

“	NULL
.-	NULL
-	NULL
<	NULL
&	NULL
-	NULL
Non-specific	NULL
binding	NULL
0.5	NULL
hr	NULL
_	NULL
1	NULL
hr	NULL
2	NULL
hr	NULL
4	NULL
hr	NULL
12	NULL
hr	NULL
py	NULL
(	NULL
5	NULL
(	NULL
5	NULL
t	NULL
&	NULL
6	NULL
A	NULL
t	NULL
LL	NULL
LL	NULL
uc	NULL
.	NULL

u	NULL
O	NULL
E	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
+	NULL
g	NULL
T	NULL
>	NULL
in	NULL
wo	NULL
Mm	NULL
m	NULL
®	NULL
®	NULL
®	NULL
m	NULL
®	NULL
m	NULL
m	NULL
m	NULL
n	NULL
~	NULL
fast	NULL
oa	NULL
o	NULL
a	NULL
a	NULL
A	NULL
a	NULL
a	NULL
n	NULL
a	NULL
n	NULL
5	NULL
2	NULL
8	NULL
8	NULL
8	NULL
8	NULL
8	NULL
58	NULL
8	NULL
8	NULL
8	NULL
8	NULL
58	NULL
8	NULL
<	NULL
p	NULL
...	NULL
.	NULL

no	NULL
«	NULL
~~	NULL
Cn	NULL
.	NULL

@	NULL
@	NULL
dip	NULL
@	NULL
@	NULL
can	NULL
an	NULL
#	NULL
#	NULL
an	NULL
#	NULL
-	NULL
in	NULL
...	NULL
1	NULL
.	NULL
'	NULL

tana	NULL
``	NULL
¥	NULL
**	NULL
.	NULL

®	NULL
«	NULL
®	NULL
-	NULL
#	NULL
Non-specific	NULL
@	NULL
ecssscsseseses®	NULL
-	NULL
=	NULL
«	NULL
-CD3	NULL
«	NULL
-CD3	NULL
+	NULL
FGF1	NULL
C*	NULL
___	NULL
g.CD3	NULL
+	NULL
«	NULL
-CD28	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
63	NULL
‘	NULL
s	NULL
mﬁé	NULL
‘	NULL
x	NULL
’	NULL
é	NULL
w	NULL
’	NULL
é	NULL
f	NULL
‘	NULL
b	NULL
’	NULL
é	NULL
c-Rel	NULL
_	NULL
.	NULL

’	NULL
*	NULL
cui	NULL
l	NULL
FGE-1	NULL
c-Rel	NULL
——|	NULL
®	NULL
nore	NULL
Nue	NULL
Nem	NULL
``	NULL
Shott	NULL
ruma	NULL
|	NULL
«	NULL
-CD3	NULL
ikd	NULL
_	NULL
,	NULL
l	NULL
<	NULL
-	NULL
<	NULL
0	NULL
00	NULL
W	NULL
ee	NULL
|	NULL
_	NULL
a-CD3+	NULL
FGF	NULL
c-Rel	NULL
-*	NULL
[	NULL
<	NULL
--	NULL
-	NULL
wes	NULL
``	NULL
veg	NULL
cant	NULL
-	NULL
l	NULL
«	NULL
-CD3	NULL
+	NULL
a-CD28	NULL
FIGURE	NULL
3	NULL
.	NULL

FGF-1	NULL
costimulation	NULL
does	NULL
not	NULL
induce	NULL
robust	NULL
nuclear	NULL
translocation	NULL
of	NULL
c-Rel	NULL
proteins	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
FGF-1	NULL
alone	NULL
,	NULL
anti-CD3	NULL
alone	NULL
,	NULL
or	NULL
anti-CD3	NULL
plus	NULL
either	NULL
FGPF-1	NULL
or	NULL
anti-CD28	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
.	NULL

Sixty	NULL
micrograms	NULL
of	NULL
nuclear	NULL
protein	NULL
per	NULL
sample	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
polyclonal	NULL
anti-c-Rel	NULL
.	NULL

Immunoreactivity	NULL
was	NULL
detected	NULL
following	NULL
incubation	NULL
with	NULL
a	NULL
peroxidase-labeled	NULL
anti-rabbit	NULL
IgG	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

Immunoreactive	NULL
c-Rel	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

There	NULL
was	NULL
a	NULL
modest	NULL
decrease	NULL
in	NULL
IxB-B	NULL
.	NULL

These	NULL
data	NULL
on	NULL
IxB-B	NULL
degradation	NULL
induced	NULL
by	NULL
CD28	NULL
stimulation	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
reported	NULL
by	NULL
Lai	NULL
and	NULL
Tan	NULL
(	NULL
38	NULL
)	NULL
and	NULL
recently	NULL
by	NULL
Kalli	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
,	NULL
but	NULL
differ	NULL
from	NULL
the	NULL
findings	NULL
of	NULL
Harhaj	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
differences	NULL
may	NULL
lie	NULL
in	NULL
the	NULL
use	NULL
of	NULL
PMA	NULL
(	NULL
34	NULL
)	NULL
rather	NULL
than	NULL
anti-CD3	NULL
in	NULL
conjunction	NULL
with	NULL
anti-CD28	NULL
.	NULL

Discussion	NULL
Signals	NULL
delivered	NULL
through	NULL
FGFRs	NULL
provide	NULL
costimulatory	NULL
pathways	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
lymphocytes	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
at	NULL
inflammatory	NULL
lesions	NULL
characterized	NULL
by	NULL
abundant	NULL
FGP-1	NULL
expression	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

While	NULL
the	NULL
activation	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
following	NULL
engagement	NULL
of	NULL
FGFR	NULL
tyrosine	NULL
kinases	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
fully	NULL
elucidated	NULL
,	NULL
recent	NULL
data	NULL
have	NULL
clarified	NULL
FGF	NULL
signaling	NULL
pathways	NULL
in	NULL
nonhemopoietic	NULL
cells	NULL
.	NULL

In	NULL
NIH-3T3	NULL
cells	NULL
,	NULL
binding	NULL
of	NULL
FGF-1	NULL
to	NULL
FGEFR-1	NULL
results	NULL
in	NULL
receptor	NULL
autophosphorylation	NULL
on	NULL
six	NULL
tyrosine	NULL
residues	NULL
,	NULL
including	NULL
residues	NULL
that	NULL
are	NULL
crucial	NULL
for	NULL
functional	NULL
kinase	NULL
activity	NULL
in	NULL
the	NULL
catalytic	NULL
domain	NULL
(	NULL
Y¥653	NULL
,	NULL
Y¥654	NULL
)	NULL
,	NULL
and	NULL
additional	NULL
residues	NULL
(	NULL
Y¥766	NULL
)	NULL
that	NULL
are	NULL
required	NULL
for	NULL
the	NULL
recruitment	NULL
of	NULL
various	NULL
signaling	NULL
intermediates	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
40	NULL
)	NULL
.	NULL

These	NULL
autophosphorylation	NULL
events	NULL
trigger	NULL
the	NULL
recruitment	NULL
of	NULL
SH2	NULL
domain	NULL
proteins	NULL
,	NULL
including	NULL
phospholipase	NULL
Cy	NULL
,	NULL
Grb2	NULL
,	NULL
and	NULL
Sos	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Recruitment	NULL
of	NULL
such	NULL
SH2	NULL
domain	NULL
proteins	NULL
then	NULL
triggers	NULL
the	NULL
activation	NULL
of	NULL
Ras-dependent	NULL
signaling	NULL
events	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
MAPK	NULL
pathways	NULL
(	NULL
16	NULL
,	NULL
41	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
autophosphorylation	NULL
of	NULL
tyrosine	NULL
residues	NULL
out	NULL
CD3	NULL
CD3	NULL
unstim	NULL
FGF1	NULL
CD28	NULL
CD3	NULL
+FGF1	NULL
+	NULL
CD28	NULL
.	NULL

<	NULL
-	NULL
CD28	NULL
RC	NULL
i	NULL
-	NULL
-	NULL
soos	NULL
-	NULL
~	NULL
-	NULL
Wth	NULL
FIGURE	NULL
4	NULL
.	NULL

FGF-1	NULL
costimulation	NULL
does	NULL
not	NULL
result	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
the	NULL
CD28RE	NULL
,	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
FGPB-1	NULL
,	NULL
with	NULL
anti-CD28	NULL
,	NULL
or	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
FGF-1	NULL
or	NULL
anti-CD28	NULL
.	NULL

Ten	NULL
microgams	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
incubated	NULL
with	NULL
**P-labeled	NULL
oligonucleotide	NULL
probe	NULL
from	NULL
the	NULL
CD28RE	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

Anti-CD28-inducible	NULL
binding	NULL
by	NULL
the	NULL
CD28RC	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

5857	NULL
B	NULL
&	NULL
led	NULL
1	NULL
1	NULL
i	NULL
ho	NULL
1	NULL
CAT	NULL
Activity	NULL
(	NULL
Relative	NULL
fold	NULL
induction	NULL
)	NULL
Unstim	NULL
_	NULL
FGF	NULL
aCD3	NULL
-	NULL
aCcD3+	NULL
aCD3+	NULL
FGF	NULL
aC028	NULL
FIGURE	NULL
5	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
proteins	NULL
activated	NULL
by	NULL
FGF-1	NULL
are	NULL
transcriptionally	NULL
active	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-CAT	NULL
reporter	NULL
construct	NULL
derived	NULL
from	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
sequence	NULL
from	NULL
the	NULL
HIV-1	NULL
virus	NULL
as	NULL
detailed	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
relative	NULL
fold	NULL
induction	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
five	NULL
different	NULL
experiments	NULL
.	NULL

side	NULL
the	NULL
catalytic	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
FGFR-1	NULL
signaling	NULL
,	NULL
as	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
these	NULL
noncatalytic	NULL
tyrosine	NULL
residues	NULL
does	NULL
not	NULL
inhibit	NULL
activation	NULL
of	NULL
the	NULL
Ras/MAPK	NULL
pathway	NULL
or	NULL
cell	NULL
proliferation	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
FGF	NULL
downstream	NULL
signaling	NULL
events	NULL
are	NULL
shared	NULL
with	NULL
cAMP	NULL
pathways	NULL
,	NULL
as	NULL
FGF/Ras-me-diated	NULL
gene	NULL
activation	NULL
in	NULL
neuroblastoma	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
transcription	NULL
of	NULL
the	NULL
ATFE/AP-1	NULL
factors	NULL
c-Jun	NULL
and	NULL
ATE-3	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
bind	NULL
to	NULL
cAMP	NULL
response	NULL
element-2	NULL
(	NULL
18	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrating	NULL
induction	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
FGF-2	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
that	NULL
the	NULL
FGF-inducible	NULL
response	NULL
element	NULL
from	NULL
the	NULL
syndecan	NULL
gene	NULL
contains	NULL
novel	NULL
AP-1	NULL
binding	NULL
motifs	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
are	NULL
,	NULL
to	NULL
the	NULL
best	NULL
of	NULL
our	NULL
knowledge	NULL
,	NULL
the	NULL
first	NULL
direct	NULL
demonstration	NULL
of	NULL
Rel/kB	NULL
activation	NULL
following	NULL
interaction	NULL
of	NULL
FGF-1	NULL
with	NULL
FGFR-1	NULL
.	NULL

Recent	NULL
reports	NULL
by	NULL
two	NULL
laboratories	NULL
80	NULL
f	NULL
Ss	NULL
5	NULL
Q5	NULL
«	NULL
&	NULL
Mig	NULL
&	NULL
.§	NULL
alk	NULL
IkB-a	NULL
lts	NULL
=	NULL
__	NULL
«	NULL
-CD3	NULL
+	NULL
FGF-1	NULL
IkB-B	NULL
Q-	NULL
Gem	NULL
comme	NULL
coe	NULL
ce	NULL
IkB-a	NULL
CHED	NULL
sm	NULL
.	NULL

»	NULL
a-CD3	NULL
+	NULL
a-CD28	NULL
IKB-B	NULL
h	NULL
e	NULL
IkB-a	NULL
She	NULL
Hite	NULL
Chl	NULL
cmm	NULL
a-CD3	NULL
FIGURE	NULL
6	NULL
.	NULL

FGF-1	NULL
costimulation	NULL
targets	NULL
the	NULL
degradation	NULL
of	NULL
Jurkat	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
FGP-1	NULL
or	NULL
anti-CD28	NULL
.	NULL

Cytoplasmic	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

One	NULL
hundred	NULL
micrograms	NULL
of	NULL
cytoplasmic	NULL
protein	NULL
extract	NULL
was	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
rabbit	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
I	NULL
«	NULL
B-a	NULL
or	NULL
IxB-B	NULL
.	NULL

Bands	NULL
were	NULL
visualized	NULL
following	NULL
incubation	NULL
with	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

5858	NULL
examining	NULL
expression	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
mesoderm	NULL
of	NULL
developing	NULL
chick	NULL
limb	NULL
bud	NULL
have	NULL
demonstrated	NULL
a	NULL
relationship	NULL
between	NULL
other	NULL
FGFs	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
.	NULL

In	NULL
both	NULL
studies	NULL
either	NULL
ex-ogenous	NULL
FGF-8	NULL
(	NULL
19	NULL
)	NULL
or	NULL
FGF-4	NULL
(	NULL
20	NULL
)	NULL
was	NULL
capable	NULL
of	NULL
reconstituting	NULL
c-Rel	NULL
mesodermal	NULL
expression	NULL
and	NULL
normal	NULL
limb	NULL
formation	NULL
following	NULL
excision	NULL
of	NULL
the	NULL
apical	NULL
ectodermal	NULL
ridge	NULL
,	NULL
a	NULL
known	NULL
source	NULL
of	NULL
FGFs	NULL
that	NULL
regulate	NULL
limb	NULL
development	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
other	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
p50	NULL
or	NULL
p65	NULL
,	NULL
was	NULL
not	NULL
addressed	NULL
in	NULL
these	NULL
reports	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
an	NULL
intermediary	NULL
protein	NULL
remains	NULL
a	NULL
possibility	NULL
.	NULL

Nonetheless	NULL
,	NULL
taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
FGEFRs	NULL
in	NULL
both	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
mesoderm	NULL
directly	NULL
activate	NULL
Rel/kB	NULL
.	NULL

It	NULL
is	NULL
not	NULL
evident	NULL
from	NULL
the	NULL
studies	NULL
in	NULL
chick	NULL
limb	NULL
which	NULL
FGFRs	NULL
mediate	NULL
c-Rel	NULL
activation	NULL
;	NULL
however	NULL
,	NULL
previous	NULL
investigations	NULL
have	NULL
shown	NULL
that	NULL
functional	NULL
FGFR-1	NULL
and	NULL
FGFR-2	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
limb	NULL
development	NULL
in	NULL
vertebrates	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
demonstrate	NULL
substantial	NULL
c-Rel	NULL
activation	NULL
by	NULL
FGE-1	NULL
and	NULL
FGFR-1	NULL
.	NULL

The	NULL
results	NULL
may	NULL
suggest	NULL
that	NULL
FGF	NULL
family	NULL
members	NULL
and	NULL
distinct	NULL
FGFRs	NULL
differentially	NULL
regulate	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
nontransformed	NULL
T	NULL
cells	NULL
that	NULL
express	NULL
FGFR-1	NULL
,	NULL
such	NULL
as	NULL
those	NULL
in	NULL
RA	NULL
synovium	NULL
(	NULL
5	NULL
)	NULL
,	NULL
may	NULL
be	NULL
regulated	NULL
differently	NULL
.	NULL

While	NULL
the	NULL
function	NULL
of	NULL
FGF-1	NULL
as	NULL
a	NULL
secondary	NULL
signal	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
analogous	NULL
to	NULL
costimulation	NULL
through	NULL
CD28	NULL
pathways	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
these	NULL
two	NULL
pathways	NULL
are	NULL
distinct	NULL
.	NULL

The	NULL
failure	NULL
of	NULL
FGF-1-induced	NULL
nuclear	NULL
proteins	NULL
to	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
the	NULL
CD28RE	NULL
coupled	NULL
with	NULL
the	NULL
minimal	NULL
c-Rel	NULL
in	NULL
these	NULL
complexes	NULL
indicate	NULL
that	NULL
the	NULL
Rel/kB	NULL
complexes	NULL
are	NULL
not	NULL
identical	NULL
in	NULL
FGF-1	NULL
and	NULL
CD28	NULL
pathways	NULL
.	NULL

Recent	NULL
data	NULL
show	NULL
that	NULL
while	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
are	NULL
all	NULL
components	NULL
of	NULL
the	NULL
CD28RC	NULL
,	NULL
only	NULL
RelA	NULL
and	NULL
c-Rel	NULL
directly	NULL
bind	NULL
to	NULL
and	NULL
trans-activate	NULL
the	NULL
CD28RE	NULL
(	NULL
22	NULL
,	NULL
24	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
c-Rel	NULL
by	NULL
CD28	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
determinant	NULL
of	NULL
CD28RE	NULL
transcriptional	NULL
activity	NULL
,	NULL
as	NULL
overexpression	NULL
of	NULL
c-rel	NULL
augments	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CD28RE	NULL
(	NULL
23	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
T	NULL
cells	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
demonstrate	NULL
the	NULL
presence	NULL
of	NULL
substantial	NULL
c-Rel	NULL
in	NULL
FGF-1-induced	NULL
complexes	NULL
,	NULL
and	NULL
this	NULL
lack	NULL
of	NULL
c-Rel	NULL
activation	NULL
may	NULL
provide	NULL
one	NULL
explanation	NULL
for	NULL
the	NULL
relatively	NULL
weak	NULL
transcriptional	NULL
activity	NULL
of	NULL
FGF-induced	NULL
complexes	NULL
and	NULL
their	NULL
inability	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
CD28RE	NULL
.	NULL

Finally	NULL
,	NULL
recent	NULL
evidence	NULL
suggests	NULL
that	NULL
CD28	NULL
costimulation	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
the	NULL
CD28RE	NULL
requires	NULL
binding	NULL
of	NULL
factors	NULL
unrelated	NULL
to	NULL
Rel/xB	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
44	NULL
)	NULL
,	NULL
and	NULL
NF-MATp35	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Such	NULL
proteins	NULL
may	NULL
not	NULL
be	NULL
recruited	NULL
in	NULL
response	NULL
to	NULL
FGF-1	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
events	NULL
may	NULL
differ	NULL
in	NULL
other	NULL
types	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
such	NULL
that	NULL
FGF-1	NULL
costimulation	NULL
in	NULL
nontransformed	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
or	NULL
its	NULL
effects	NULL
within	NULL
inflammatory	NULL
sites	NULL
may	NULL
include	NULL
c-Rel	NULL
activation	NULL
.	NULL

Experiments	NULL
are	NULL
currently	NULL
in	NULL
progress	NULL
to	NULL
determine	NULL
these	NULL
possibilities	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
FGF-1	NULL
and	NULL
anti-CD28	NULL
increases	NULL
NF-KB	NULL
translocation	NULL
in	NULL
Jurkat	NULL
without	NULL
increasing	NULL
IL-2	NULL
production	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
outcome	NULL
of	NULL
these	NULL
signals	NULL
may	NULL
also	NULL
differ	NULL
in	NULL
nontransformed	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
experiments	NULL
to	NULL
characterize	NULL
these	NULL
events	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

Differential	NULL
degradation	NULL
of	NULL
the	NULL
NF-KB	NULL
cytoplasmic	NULL
inhibitors	NULL
IxB-a	NULL
and	NULL
IxB-B	NULL
was	NULL
examined	NULL
to	NULL
determine	NULL
how	NULL
FGF-1	NULL
regulates	NULL
the	NULL
induction	NULL
of	NULL
Rel/kB	NULL
complexes	NULL
.	NULL

Emerging	NULL
data	NULL
suggest	NULL
that	NULL
control	NULL
of	NULL
differential	NULL
complex	NULL
induction	NULL
by	NULL
various	NULL
stimuli	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
targeted	NULL
degradation	NULL
of	NULL
either	NULL
IxB-a	NULL
@	NULL
or	NULL
IxB-	NULL
$	NULL
B	NULL
.	NULL

Degradation	NULL
of	NULL
I	NULL
«	NULL
B-a	NULL
@	NULL
has	NULL
been	NULL
linked	NULL
to	NULL
the	NULL
nuclear	NULL
induction	NULL
of	NULL
p50/p65	NULL
heterodimers	NULL
,	NULL
the	NULL
classic	NULL
NF-kB	NULL
complexes	NULL
induced	NULL
by	NULL
a	NULL
broad	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
mitogens	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
various	NULL
cytokines	NULL
(	NULL
GM-CSF	NULL
,	NULL
TNF-a	NULL
)	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
targeted	NULL
degradation	NULL
of	NULL
IxB-B	NULL
is	NULL
restricted	NULL
to	NULL
only	NULL
a	NULL
few	NULL
stimulators	NULL
,	NULL
including	NULL
LPS	NULL
and	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus-1	NULL
Tax	NULL
protein	NULL
(	NULL
34	NULL
)	NULL
.	NULL

CD28	NULL
signaling	NULL
targets	NULL
both	NULL
a	NULL
and	NULL
B	NULL
isoforms	NULL
,	NULL
as	NULL
this	NULL
pathway	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
prolong	NULL
both	NULL
PMA-	NULL
and	NULL
anti-CD3	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION	NULL
BY	NULL
FGF-1	NULL
induced	NULL
degradation	NULL
of	NULL
IxB-a	NULL
@	NULL
and	NULL
to	NULL
induce	NULL
the	NULL
degradation	NULL
of	NULL
an	NULL
event	NULL
that	NULL
is	NULL
not	NULL
targeted	NULL
by	NULL
PMA	NULL
activation	NULL
alone	NULL
(	NULL
34	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
FGF-1	NULL
targets	NULL
the	NULL
degradation	NULL
of	NULL
as	NULL
FGF-1	NULL
plus	NULL
anti-CD3	NULL
enhances	NULL
and	NULL
substantially	NULL
prolongs	NULL
the	NULL
modest	NULL
IxB-a	NULL
degradation	NULL
induced	NULL
by	NULL
anti-CD3	NULL
alone	NULL
.	NULL

Little	NULL
effect	NULL
on	NULL
I	NULL
«	NULL
B-	NULL
B	NULL
degradation	NULL
was	NULL
observed	NULL
in	NULL
our	NULL
studies	NULL
.	NULL

This	NULL
FGF-1	NULL
targeting	NULL
of	NULL
IxB-	NULL
«	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
FGF-1	NULL
induction	NULL
of	NULL
Rel/kB	NULL
complexes	NULL
that	NULL
contain	NULL
mostly	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
the	NULL
heterodimer	NULL
complex	NULL
that	NULL
is	NULL
typically	NULL
induced	NULL
with	NULL
degradation	NULL
.	NULL

While	NULL
we	NULL
demonstrate	NULL
activation	NULL
of	NULL
Rel/kB	NULL
proteins	NULL
following	NULL
FGE-1/FGFR-1	NULL
interaction	NULL
,	NULL
this	NULL
could	NULL
be	NULL
a	NULL
response	NULL
unique	NULL
to	NULL
specific	NULL
combinations	NULL
of	NULL
FGFs/FGFRs	NULL
rather	NULL
than	NULL
the	NULL
FGF	NULL
family	NULL
as	NULL
a	NULL
whole	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
suggest	NULL
that	NULL
an	NULL
FGP-2-inducible	NULL
response	NULL
element	NULL
in	NULL
the	NULL
syndecan-1	NULL
promoter	NULL
does	NULL
not	NULL
bind	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
in	NULL
vivo	NULL
footprinting	NULL
revealed	NULL
three	NULL
motifs	NULL
that	NULL
bind	NULL
nuclear	NULL
factors	NULL
in	NULL
response	NULL
to	NULL
FGF-2	NULL
activation	NULL
.	NULL

While	NULL
two	NULL
of	NULL
these	NULL
motifs	NULL
contained	NULL
AP-1-like	NULL
consensus	NULL
sites	NULL
,	NULL
the	NULL
remaining	NULL
motif	NULL
contained	NULL
no	NULL
known	NULL
consensus	NULL
se-quences	NULL
.	NULL

Binding	NULL
competition	NULL
experiments	NULL
with	NULL
an	NULL
array	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
in	NULL
gel-shift	NULL
experiments	NULL
did	NULL
not	NULL
reveal	NULL
inhibition	NULL
of	NULL
any	NULL
protein	NULL
complexes	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotides	NULL
,	NULL
suggesting	NULL
that	NULL
Rel/kB	NULL
proteins	NULL
are	NULL
not	NULL
crucial	NULL
for	NULL
the	NULL
FGF-2-responsive	NULL
expression	NULL
of	NULL
syndecan-1	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
activated	NULL
by	NULL
FGE-1	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
other	NULL
proteins	NULL
play	NULL
critical	NULL
roles	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
FGF-1-responsive	NULL
elements	NULL
in	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
complex	NULL
array	NULL
of	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
found	NULL
in	NULL
inflammatory	NULL
sites	NULL
where	NULL
FGFR-1*	NULL
T	NULL
cells	NULL
accumulate	NULL
may	NULL
further	NULL
alter	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
FGF-1	NULL
responses	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Zhi-Liang	NULL
Chu	NULL
for	NULL
assistance	NULL
with	NULL
the	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Gospodarowicz	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Neufeld	NULL
,	NULL
and	NULL
L.	NULL
Schweigerer	NULL
.	NULL

1987	NULL
.	NULL

Fibroblast	NULL
growth	NULL
factor	NULL
:	NULL
structural	NULL
and	NULL
biological	NULL
properties	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

5	NULL
(	NULL
Suppl	NULL
.	NULL
)	NULL

:15	NULL
.	NULL

2	NULL
.	NULL

Burgess	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Maciag	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
heparin-binding	NULL
(	NULL
fibroblast	NULL
)	NULL
growth	NULL
factor	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:575	NULL
.	NULL

3	NULL
.	NULL

Basilico	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
D.	NULL
Moscatelli	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
FGF	NULL
family	NULL
of	NULL
growth	NULL
factors	NULL
and	NULL
oncogenes	NULL
.	NULL

Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

59:115	NULL
.	NULL

4	NULL
.	NULL

Mason	NULL
,	NULL
I.	NULL
J	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
ins	NULL
and	NULL
outs	NULL
of	NULL
fibroblast	NULL
growth	NULL
factors	NULL
.	NULL

Cell	NULL
78:547	NULL
.	NULL

5	NULL
.	NULL

Byrd	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
X.	NULL
M.	NULL
Zhao	NULL
,	NULL
W.	NULL
L.	NULL
McKechan	NULL
,	NULL
G.	NULL
G.	NULL
Miller	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Thomas	NULL
.	NULL

1996	NULL
.	NULL

Expression	NULL
and	NULL
functional	NULL
expansion	NULL
of	NULL
FGF	NULL
receptor	NULL
T	NULL
cells	NULL
in	NULL
rheumatoid	NULL
synovium	NULL
and	NULL
peripheral	NULL
blood	NULL
of	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

39:914	NULL
.	NULL

6	NULL
.	NULL

Sano	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Forough	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
M.	NULL
Maier	NULL
,	NULL
J.	NULL
P.	NULL
Case	NULL
,	NULL
A.	NULL
Jackson	NULL
,	NULL
K.	NULL
Engleka	NULL
,	NULL
T.	NULL
Maciag	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Wilder	NULL
.	NULL

1990	NULL
.	NULL

Detection	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
heparin	NULL
binding	NULL
growth	NULL
factor-1	NULL
(	NULL
acidic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
)	NULL
in	NULL
inflammatory	NULL
arthritic	NULL
joints	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

110:1417	NULL
.	NULL

7	NULL
.	NULL

Sano	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Engleka	NULL
,	NULL
P.	NULL
Mathern	NULL
,	NULL
L.	NULL
J.	NULL
Crofford	NULL
,	NULL
E.	NULL
F.	NULL
Remmers	NULL
,	NULL
C.	NULL
L.	NULL
Jelsema	NULL
,	NULL
E.	NULL
Goldmuntz	NULL
,	NULL
T.	NULL
Maciag	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Wilder	NULL
.	NULL

1993	NULL
.	NULL

Coexpression	NULL
of	NULL
phosphoty-rosine-containing	NULL
proteins	NULL
,	NULL
platelet-derived	NULL
growth	NULL
factor-B	NULL
,	NULL
and	NULL
fibroblast	NULL
growth	NULL
factor-1	NULL
in	NULL
situ	NULL
in	NULL
synovial	NULL
tissues	NULL
of	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
Lewis	NULL
rats	NULL
with	NULL
adjuvant	NULL
or	NULL
streptococcal	NULL
cell	NULL
wall	NULL
arthritis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91	NULL
:	NULL
553	NULL
.	NULL

8	NULL
.	NULL

Remmers	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
H.	NULL
Sano	NULL
,	NULL
R.	NULL
Lafyatis	NULL
,	NULL
J.	NULL
P.	NULL
Case	NULL
,	NULL
G.	NULL
K.	NULL
Kumkumian	NULL
,	NULL
T.	NULL
Maciag	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Wilder	NULL
.	NULL

1991	NULL
.	NULL

Production	NULL
of	NULL
platelet	NULL
derived	NULL
growth	NULL
factor	NULL
B	NULL
chain	NULL
(	NULL
PDGF-B/c-Sis	NULL
)	NULL
mRNA	NULL
and	NULL
immunoreactive	NULL
PDGF	NULL
B-like	NULL
polypeptide	NULL
by	NULL
theu-matoid	NULL
synovium	NULL
:	NULL
coexpression	NULL
with	NULL
heparin	NULL
binding	NULL
acidic	NULL
fibroblast	NULL
growth	NULL
factor-1	NULL
.	NULL

J.	NULL
Rheumatol	NULL
.	NULL

18:7	NULL
.	NULL

9	NULL
.	NULL

Zhao	NULL
,	NULL
X.	NULL
M.	NULL
,	NULL
B.	NULL
S.	NULL
Citrin	NULL
,	NULL
G.	NULL
G.	NULL
Miller	NULL
,	NULL
W.	NULL
H.	NULL
Frist	NULL
,	NULL
W.	NULL
H.	NULL
Merrill	NULL
,	NULL
T.	NULL
A.	NULL
Fischell	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Atkinson	NULL
,	NULL
and	NULL
T.	NULL
K.	NULL
Yeoh	NULL
.	NULL

1995	NULL
.	NULL

Association	NULL
of	NULL
acidic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
and	NULL
untreated	NULL
low	NULL
grade	NULL
rejection	NULL
with	NULL
cardiac	NULL
allograft	NULL
vasculopathy	NULL
.	NULL

Transplantation	NULL
59:1005	NULL
.	NULL

10	NULL
.	NULL

Zhao	NULL
,	NULL
X.	NULL
M.	NULL
,	NULL
T.	NULL
K.	NULL
Yeoh	NULL
,	NULL
M.	NULL
Hiebert	NULL
,	NULL
W.	NULL
H.	NULL
Frist	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Miller	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
acidic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
(	NULL
heparin-binding	NULL
growth	NULL
factor-1	NULL
)	NULL
and	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
cardiac	NULL
allografts	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Transplantation	NULL
56:1177	NULL
.	NULL

11	NULL
.	NULL

Johnson	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Torres	NULL
.	NULL

1985	NULL
.	NULL

Peptide	NULL
growth	NULL
factors	NULL
PDGF	NULL
,	NULL
EGF	NULL
,	NULL
and	NULL
FGF	NULL
regulate	NULL
interferon-y	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:2824	NULL
.	NULL

12	NULL
.	NULL

Byrd	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
X.	NULL
M.	NULL
Zhao	NULL
,	NULL
G.	NULL
G.	NULL
Miller	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Thomas	NULL
.	NULL

1995	NULL
.	NULL

Detection	NULL
of	NULL
T	NULL
cells	NULL
responsive	NULL
to	NULL
a	NULL
vascular	NULL
growth	NULL
factor	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Immunol	NULL
.	NULL

Res	NULL
.	NULL

541:139	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

Zhao	NULL
,	NULL
X.	NULL
M.	NULL
,	NULL
V.	NULL
M.	NULL
Byrd	NULL
,	NULL
W.	NULL
L.	NULL
McKechan	NULL
,	NULL
M.	NULL
B.	NULL
Reich	NULL
,	NULL
G.	NULL
G.	NULL
Miller	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Thomas	NULL
.	NULL

1995	NULL
.	NULL

Costimulation	NULL
of	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
by	NULL
fibroblast	NULL
growth	NULL
factor-1	NULL
(	NULL
acidic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:3904	NULL
.	NULL

Jaye	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Schlessinger	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dionne	NULL
.	NULL

1992	NULL
.	NULL

Fibroblast	NULL
growth	NULL
factor	NULL
receptor	NULL
tyrosine	NULL
kinases	NULL
:	NULL
molecular	NULL
analysis	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

Biochim	NULL
.	NULL

Bio-phys	NULL
.	NULL

Acta	NULL
1135:185	NULL
.	NULL

Shi	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Kan	NULL
,	NULL
J.	NULL
Xu	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
J.	NULL
Hou	NULL
,	NULL
and	NULL
W.	NULL
L.	NULL
McKechan	NULL
.	NULL

1993	NULL
.	NULL

Control	NULL
of	NULL
fibroblast	NULL
growth	NULL
factor	NULL
receptor	NULL
kinase	NULL
signal	NULL
transduction	NULL
by	NULL
heterodimerization	NULL
of	NULL
combinatorial	NULL
splice	NULL
variants	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3907	NULL
.	NULL

Kouhara	NULL
,	NULL
H.	NULL
,	NULL
Y.	NULL
R.	NULL
Hadari	NULL
,	NULL
T.	NULL
Spivak-Kroizman	NULL
,	NULL
J.	NULL
Schilling	NULL
,	NULL
D.	NULL
Bar-Sagi	NULL
,	NULL
I.	NULL
Lax	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
lipid-anchored	NULL
Grb2-binding	NULL
protein	NULL
that	NULL
links	NULL
FGF-receptor	NULL
activation	NULL
to	NULL
the	NULL
Ras/MAPK	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
89:693	NULL
.	NULL

Janet	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Labourdette	NULL
,	NULL
M.	NULL
Sensenbrenner	NULL
,	NULL
and	NULL
B.	NULL
Pettmann	NULL
.	NULL

1992	NULL
.	NULL

Mitogenic	NULL
growth	NULL
factors	NULL
regulate	NULL
differentially	NULL
early	NULL
gene	NULL
mRNA	NULL
expression	NULL
:	NULL
a	NULL
study	NULL
on	NULL
two	NULL
clones	NULL
of	NULL
3T3	NULL
fibroblasts	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
.	NULL

Res	NULL
.	NULL

198:305	NULL
.	NULL

Tan	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
G.	NULL
Low	NULL
,	NULL
C.	NULL
Boccia	NULL
,	NULL
J.	NULL
Grossman	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Comb	NULL
.	NULL

1994	NULL
.	NULL

Fibroblast	NULL
growth	NULL
factor	NULL
and	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
synergistically	NULL
activate	NULL
gene	NULL
expression	NULL
at	NULL
a	NULL
cAMP	NULL
response	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7546	NULL
.	NULL

Kanegae	NULL
,	NULL
Y.	NULL
,	NULL
A.	NULL
T.	NULL
Tavares	NULL
,	NULL
J.	NULL
C.	NULL
Belmonte	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1998	NULL
.	NULL

Role	NULL
of	NULL
Rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
during	NULL
the	NULL
outgrowth	NULL
of	NULL
the	NULL
vertebrate	NULL
limb	NULL
.	NULL

Nature	NULL
392:611	NULL
.	NULL

Bushdid	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
D.	NULL
M.	NULL
Brantley	NULL
,	NULL
F.	NULL
E.	NULL
Yull	NULL
,	NULL
G.	NULL
L.	NULL
Blacuer	NULL
,	NULL
L.	NULL
H.	NULL
Hoffman	NULL
,	NULL
L.	NULL
Niswander	NULL
,	NULL
and	NULL
L.	NULL
D.	NULL
Kerr	NULL
.	NULL

1998	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-KB	NULL
activity	NULL
results	NULL
in	NULL
disruption	NULL
of	NULL
the	NULL
apical	NULL
ectodermal	NULL
ridge	NULL
and	NULL
aberrant	NULL
limb	NULL
morphogenesis	NULL
.	NULL

Nature	NULL
392:615	NULL
.	NULL

Bryan	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
J.	NULL
H.	NULL
Lai	NULL
,	NULL
M.	NULL
Van	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
R.	NULL
R.	NULL
Rich	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1994	NULL
.	NULL

Effect	NULL
of	NULL
CD28	NULL
signal	NULL
transduction	NULL
on	NULL
c-Rel	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7933	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
G.	NULL
Horvath	NULL
,	NULL
J.	NULL
Subleski	NULL
,	NULL
J.	NULL
Bruder	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1995	NULL
.	NULL

RelA	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD28	NULL
response	NULL
element	NULL
within	NULL
the	NULL
interleukin	NULL
2	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4260	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Tan	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
and	NULL
H.	NULL
Young	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-KB	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1696	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
G.	NULL
Horvath	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1995	NULL
.	NULL

Mechanisms	NULL
of	NULL
enhanced	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
c-Rel	NULL
and	NULL
NF-KB	NULL
by	NULL
CD28	NULL
costimulation	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

766:220	NULL
.	NULL

Dikov	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Reich	NULL
,	NULL
L.	NULL
Dworkin	NULL
,	NULL
J.	NULL
W.	NULL
Thomas	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Miller	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
functional	NULL
fibroblast	NULL
growth	NULL
factor-1	NULL
immunoglobulin	NULL
fusion	NULL
protein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:15811	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
Mckinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
QI	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
requires	NULL
site-specific	NULL
ubiquitination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11259	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992.	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transacti-vation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339	NULL
.	NULL

Chu	NULL
,	NULL
Z.	NULL
,	NULL
T.	NULL
A.	NULL
Mckinsey	NULL
,	NULL
L.	NULL
Liu	NULL
,	NULL
X.	NULL
Qi	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1996	NULL
.	NULL

Basal	NULL
phosphorylation	NULL
of	NULL
the	NULL
PEST	NULL
domain	NULL
in	NULL
IxB-f	NULL
regulates	NULL
its	NULL
functional	NULL
interaction	NULL
with	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
product	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:5974	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

5859	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Stevenson	NULL
,	NULL
E.	NULL
W.	NULL
Schwarz	NULL
,	NULL
D.	NULL
V.	NULL
Antwerp	NULL
,	NULL
and	NULL
S.	NULL
Miyamoto	NULL
.	NULL

1995	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B/IKkB	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2723	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
IKB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5169	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

Liquid	NULL
scintillation	NULL
detection	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

BioTechniques	NULL
5:444	NULL
.	NULL

Harhaj	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
S.	NULL
B.	NULL
Maggirwar	NULL
,	NULL
L.	NULL
Good	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Sun	NULL
.	NULL

1996	NULL
.	NULL

CD28	NULL
mediates	NULL
a	NULL
potent	NULL
costimulatory	NULL
signal	NULL
for	NULL
the	NULL
rapid	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
B-B	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
accelerated	NULL
activation	NULL
of	NULL
various	NULL
NF-kB/Rel	NULL
heterodimers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:6736	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Loh	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333	NULL
.	NULL

Schwartz	NULL
,	NULL
R.	NULL
H.	NULL
1992	NULL
.	NULL

Costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
:	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
,	NULL
CTLA-4	NULL
,	NULL
and	NULL
B7/BB1	NULL
in	NULL
interleukin-2	NULL
production	NULL
and	NULL
immunotherapy	NULL
.	NULL

Cell	NULL
71	NULL
:	NULL
1065	NULL
.	NULL

Tran	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Merika	NULL
,	NULL
and	NULL
D.	NULL
Thanos	NULL
.	NULL

1997	NULL
.	NULL

Distinct	NULL
functional	NULL
properties	NULL
of	NULL
IkBa	NULL
and	NULL
IBB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:5386	NULL
.	NULL

Lai	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Tan	NULL
.	NULL

1994	NULL
.	NULL

CD28	NULL
signaling	NULL
causes	NULL
a	NULL
sustained	NULL
down-regulation	NULL
of	NULL
IkB-a	NULL
which	NULL
can	NULL
be	NULL
prevented	NULL
by	NULL
the	NULL
immunosuppressant	NULL
rapamycin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30077	NULL
.	NULL

Kalli	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Huntoon	NULL
,	NULL
M.	NULL
Bell	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
McKean	NULL
.	NULL

1998	NULL
.	NULL

Mechanism	NULL
responsible	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor-	NULL
and	NULL
€D28-	NULL
or	NULL
interleukin	NULL
1	NULL
(	NULL
IL-1	NULL
)	NULL
receptor-initiated	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
by	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:3140	NULL
.	NULL

Mohammadi	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Dikic	NULL
,	NULL
A.	NULL
Sorokin	NULL
,	NULL
W.	NULL
H.	NULL
Burgess	NULL
,	NULL
M.	NULL
Jaye	NULL
,	NULL
and	NULL
J.	NULL
Schlessinger	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
six	NULL
novel	NULL
autophosphorylation	NULL
sites	NULL
on	NULL
fibroblast	NULL
growth	NULL
factor	NULL
receptor	NULL
1	NULL
and	NULL
elucidation	NULL
of	NULL
their	NULL
importance	NULL
in	NULL
receptor	NULL
activation	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:977	NULL
.	NULL

Jaakkola	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Vihinen	NULL
,	NULL
A.	NULL
Maatta	NULL
,	NULL
and	NULL
M.	NULL
Jalkanen	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
an	NULL
enhancer	NULL
on	NULL
the	NULL
syndecan-1	NULL
gene	NULL
is	NULL
restricted	NULL
to	NULL
fibroblast	NULL
growth	NULL
factor	NULL
family	NULL
members	NULL
in	NULL
mesenchymal	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17:3210	NULL
.	NULL

MacArthur	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
A.	NULL
Lawshe	NULL
,	NULL
J.	NULL
Xu	NULL
,	NULL
S.	NULL
Santos-Ocampo	NULL
,	NULL
M.	NULL
Heikinheimo	NULL
,	NULL
A.	NULL
T.	NULL
Chellaiah	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Ornitz	NULL
.	NULL

1995	NULL
.	NULL

FGF-8	NULL
isoforms	NULL
activate	NULL
receptor	NULL
splice	NULL
forms	NULL
that	NULL
are	NULL
expressed	NULL
in	NULL
mesenchymal	NULL
regions	NULL
of	NULL
mouse	NULL
development	NULL
.	NULL

Development	NULL
121	NULL
(	NULL
Suppl	NULL
.	NULL
)	NULL

:3603	NULL
.	NULL

Deng	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Bedford	NULL
,	NULL
C.	NULL
Li	NULL
,	NULL
X.	NULL
Xu	NULL
,	NULL
X.	NULL
Yang	NULL
,	NULL
J.	NULL
Dunmore	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1997	NULL
.	NULL

Fibroblast	NULL
growth	NULL
factor	NULL
receptor-1	NULL
(	NULL
FGFR-1	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
neural	NULL
tube	NULL
and	NULL
limb	NULL
development	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

185:42.	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1996	NULL
.	NULL

High	NULL
mobility	NULL
group	NULL
protein	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
for	NULL
function	NULL
and	NULL
for	NULL
c-Rel	NULL
binding	NULL
to	NULL
CD28	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
GM-CSF	NULL
and	NULL
IL-2	NULL
promoters	NULL
.	NULL

Immunity	NULL
5:479	NULL
.	NULL

Civil	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Bakker	NULL
,	NULL
I.	NULL
Rensink	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
L.	NULL
A.	NULL
Aarden	NULL
,	NULL
and	NULL
C.	NULL
L.	NULL
Verweij	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
appearance	NULL
of	NULL
a	NULL
factor	NULL
that	NULL
binds	NULL
the	NULL
CD28	NULL
response	NULL
clement	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
correlates	NULL
with	NULL
interleukin-2	NULL
production	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:8321	NULL
.	NULL

